Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyell Immunopharma, Inc.

0.4648
-0.0002-0.04%
Post-market: 0.4508-0.0140-3.01%17:31 EDT
Volume:723.82K
Turnover:342.50K
Market Cap:137.22M
PE:-0.35
High:0.4966
Open:0.4592
Low:0.4400
Close:0.4650
Loading ...

Director’s Bold Move: Major Stock Purchase in Lyell Immunopharma!

TIPRANKS
·
03 Apr

Lyell Immunopharma to Cut Jobs, Close West Hills Plant

Dow Jones
·
02 Apr

BRIEF-Lyell Immunopharma Inc - To Close West Hills Manufacturing Facility - SEC Filing

Reuters
·
02 Apr

Lyell Immunopharma Inc - to Close West Hills Manufacturing Facility - SEC Filing

THOMSON REUTERS
·
02 Apr

Lyell Immunopharma Inc: Reiterates Its Financial Guidance

THOMSON REUTERS
·
02 Apr

Investor Interest in Lyell Immunopharma Stock (LYEL) Surges on Positive Analyst Report

TIPRANKS
·
23 Mar

Favourable Signals For Lyell Immunopharma: Numerous Insiders Acquired Stock

Simply Wall St.
·
20 Mar

Lyell Immunopharma Price Target Maintained With a $1.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Mar

Lyell Immunopharma’s Global Expansion Strategy: Navigating Risks and Challenges

TIPRANKS
·
13 Mar

Lyell Immunopharma Q4 Sales $11.00K Down From $13.00K YoY

Benzinga
·
12 Mar

BRIEF-Lyell Immunopharma Q4 Net Income USD -191.935 Million

Reuters
·
12 Mar

Lyell Immunopharma Q4 Revenue USD 11 Thousand

THOMSON REUTERS
·
12 Mar

Lyell Immunopharma Q4 Operating Expenses USD 201.158 Million

THOMSON REUTERS
·
12 Mar

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences

GlobeNewswire
·
19 Feb

Following a 67% decline over last year, recent gains may please Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional owners

Simply Wall St.
·
17 Feb

Lyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 46% stake

Simply Wall St.
·
31 Jan

Lyell Immunopharma (LYEL) Upgraded to Strong Buy: Here's Why

Zacks
·
23 Jan

Lyell Immunopharma price target lowered to 60c from $1 at BofA

TIPRANKS
·
12 Jan

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Rhythm Pharmaceuticals (RYTM) and Lyell Immunopharma (LYEL)

TIPRANKS
·
11 Jan

After Plunging -31.22% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)

Zacks
·
30 Dec 2024